Teosyal RHA 2 is a hyaluronic acid-based dermal filler. Approved by the FDA for correction of moderate facial wrinkles and folds, the product is formulated with crosslinked hyaluronic acid and is designed for administration into the mid-to-deep dermis. Dermal filler Teosyal RHA 2 is designed to treat moderate lines and wrinkles on the mobile parts of the face that are involved in active stretching and in expressing emotion. Lidocaine is included in dermal filler Teosyal RHA 2 to ensure the patient experience is a comfortable one.
RHA stands for Resilient Hyaluronic Acid. Dermal filler Teosyal RHA 2 belongs to a range of fillers that were developed with the notion that areas such as the cheeks, forehead, and the area around the mouth are rarely static. Instead, these zones are dynamic, constantly moving and changing, and the dermal filler used on these areas must be malleable and allow them to stretch so that the patient can continue to produce natural-looking facial expressions post-treatment. Dermal filler Teosyal RHA 2 is designed to do just that.
Indicated for the treatment of Glabellar Lines, Nasolabial Folds, and wrinkles in the malar area, dermal filler Teosyal RHA 2 can also be used for increasing volume in the lips and for minimizing more noticeable lines on the neck and decollete. Depending on wrinkle depth, two initial sessions may be necessary to achieve optimal results. The effects of a treatment with dermal filler Teosyal RHA 2 last from six to nine months. Patients should return every six months or yearly for touch-ups.
Dermal filler Teosyal RHA 2 contains crosslinked sodium hyaluronate of non-animal origin. The hyaluronic acid concentration is 23 mg/ml; Lidocaine is present at a concentration of 3mg/ml. Teosyal RHA 2 comes as two syringes each prefilled with 1 ml of gel accompanied by 2 x 30G 1/2″needles. Dermal filler Teosyal RHA 2 is manufactured in Switzerland by Teoxane Laboratories.